a b s t r a c t
Mutations in the Jumonji AT-rich interactive domain 1C (JARID1C/SMCX/KDM5C) gene, located at Xp11. 22 , are emerging as frequent causes of X-linked intellectual disability (XLID). KDM5C encodes for a member of an ARID protein family that harbors conserved DNA-binding motifs and acts as a histone H3 lysine 4 demethylase, suggesting a potential role in epigenetic regulation during development, cell growth and differentiation. In this study, we describe clinical and genetic findings of a Brazilian family co-segregating a novel nonsense mutation (c.2172C > A) in exon 15 of KDM5C gene with the intellectual disability phenotype. The transition resulted in replacement of the normal cysteine by a premature termination codon at position 724 of the protein (p.Cys724X), leading to reduced levels of KDM5C transcript probably due to nonsense mediated mRNA decay. The clinical phenotype of the proband, who has two affected brothers and a mild cognitively impaired mother, consisted of short stature, speech delay, hyperactivity, violent behavior and high palate, besides severe mental retardation. Our findings extend the number of KDM5C mutations implicated in XLID and highlight its promise for understanding neural function and unexplained cases of XLID.
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Intellectual disability (ID), formerly known as mental retardation (MR), is characterized by substantial limitations in both intellectual functioning and adaptative behavior before the age of 18 years, and has long been recognized as a common and etiologically heterogeneous disorder, affecting 1-3% of the general population [4, 12] . Over 10% of ID cases with a Mendelian inheritance pattern have been assigned to the X chromosome, even though it carries only about 4% of all human protein-coding genes, leading to a marked excess of hemizygous males with intellectual disability as compared to females [15] . Up to now, more than 90 genes have been associated to X-Linked Intellectual Disability (XLID) [6] . Therefore, mutation frequencies in the majority of them are low, especially for the non syndromic forms of XLID (NS-XLID), which represent ∼2/3 of all XLID cases. Consequently, many of the genetic determinants of NS-XLID remain to be elucidated. Mutations that give rise to NS-XLID are not evenly distributed along the X-chromosome and seem to be clustered in regions Xp11, Xp22 and Xq26-q28 [16] . Genes located at these regions have been shown to encode for proteins involved in signaling pathways, responsible for regulating cytoskeleton organization and synaptic efficacy, besides acting in other essential functions, like chromatin remodeling dynamics [19] . Conversely to other NS-XLID genes, mutations in Jumonji ATrich interactive domain 1C (JARID1C/SMCX/KDM5C; MIM #300534), a non-pseudoautosomal brain-expressed gene located at Xp11.22, have emerged as a potential common cause for XLID. KDM5C contains 26 exons and encodes an ubiquitinous 1560-aa protein that catalyzes the removal of methyl groups from di-and tri-methylated lysine 4 on histone H3 lysine 4 (H3K4). It suggests a central transcriptional repressive role for KDM5C in chromatin dynamics and epigenetic regulation during cell growth, differentiation and development [5, 9, 21, 24] . Furthermore, the strongest expression of the predominant KDM5C transcript was observed in skeletal muscle [8] and brain, mainly in the hippocampus [23] and a biological role for this gene in neuronal survival and dendritic development has been provided [7] .
KDM5C protein is homologous to three other proteins of the human JARID1 family (JARID1A, JARID1B and JARID1C that binds methyl-lysine residues [5, 7] . Recent evidence demonstrates that KDM5C protein can be post translationally modified by ubiquitin in vitro, suggesting that this modification is functionally relevant for maintaining the proper balance between histone demethylase and methyltransferase activities [13] .
Herein, we describe clinical and genetic findings from a Brazilian family segregating a novel nonsense mutation (c.2172C > A) in KDM5C gene compatible with ID phenotype. The mutation generates a premature termination codon at position 724 of the protein (p.Cys724X) in the C5HC2 zinger finger domain, leading to reduction of KDM5C expression levels.
The Brazilian family described here consists of three affected brothers and a mild cognitively impaired mother. The propositus (TRP), a 13-year-old boy (year of birth 1996), is the fourth of five children of a young and unrelated couple. He was born by vaginal delivery after an uncomplicated pregnancy with no major intercurrence during neonatal period (birth weight = 2.54 kg; unknown length), except for the fact that he was submitted to phototherapy during the first week of life due to jaundice. At the age of 24 months, a general developmental delay was recognized (head control at 6th month of age; sitting position at 8th month of age; walking at 24th month of age and first words at 24th month of age), as well as other features such as failure to thrive, learning difficulties, aggressive behavior, hyperactivity and regular respiratory/urinary infections. Clinical investigation included normal results for inborn errors of metabolism, computed tomography (CT) scan and abdominal ultrasonography. Due to an idiopathic familial history of intellectual disability, compatible with an X-linked pattern, TRP was referred to the Human Genetics Service of the State University of Rio de Janeiro in 2005. He exhibited a normal 550 band resolution karyotype. Mutations in FMR1, FMR2, MECP2 and ARX genes were subsequently ruled out, as well as, submicroscopic duplications/deletions across chromosome X (through Multiplex Ligation-dependent Probe Amplification). At the age of 12 years and 6 months, he spoke just some words, without making a sentence and exhibited proportionate short stature (height = 130 cm, below 3rd percentile), low weight (28.85 kg, below 3rd percentile), microcephaly (head circumference = 51 cm, below 3rd percentile), high palate, slight maxillary hypoplasia and small feet, besides being severely mental retarded. Clinical features of two affected siblings are similar to the proband's, including severe ID and short stature (Fig. 1) . Both are institutionalized, but biological samples were available for only one of them.
As a short stature phenotype segregates with ID in the family, molecular analysis of KDM5C coding sequence and flanking intronic regions was performed by standard PCR according to Jensen et al. [8] , followed by bidirectional direct sequencing with the BigDye Terminator kit on an ABI3100 automated sequencer (Applied Biosystems, Foster City, USA). We found a novel c.2172C > A transition in exon 15 of KDM5C gene, which was confirmed in a new PCR from a second DNA sample from the patient. KDM5C sequencing from available members of the family proved that the truncating mutation segregates completely with the ID phenotype, since the variant was present in all genotyped individuals with ID ( Fig. 2 ; individuals II.2 and II.4) and absent in unaffected males ( Fig. 2 ; individuals II.3 and II.6).
For KDM5C expression analysis, total RNA was obtained from whole blood of two affected brothers and two unaffected brothers using the RiboPure-Blood kit (Ambion, Austin, TX). The integrity of the RNA was visualized on ethidium stained agarose gels and quantified using a ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE). For quantitative RT-PCR, 50 ng total RNA was reverse transcribed into cDNA in the presence of 1.5 g random hexamers pdN 6 (Invitrogen, Carlsbad, CA) and 0.33 mM dNTP in a total volume of 30 l using the Roche (Mannheim, Germany) First Strand cDNA Synthesis Kit. PCR amplifications were performed in triplicates of 25 l reactions in the presence of SYBR green (Applied Biosystems, Foster City, CA). Quantitations were performed using the absolute quantification setting on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA) and a standard curve generated by serial dilution (factor 2) of a control cDNA. The PCR primers contain the following sequences: KDM5C F: 5 -CATCATGGTGCAAGAAGAGC-3 ; KDM5C R: 5 -ATGTGGGAAAGGCAGACAAG-3 ; GAPDH F: 5 -CCACCCATGGCAAATTCC-3 and GAPDH R: 5 -TGGGATTTCCATTGATGACAAG-3 . The institutional Ethics Committee has approved all procedures and samples from TRP patient and relatives were obtained after receiving informed consent.
We identified a novel c.2172C > A transition in exon 15 of KDM5C gene, which resulted in substitution of the original cysteine by a premature termination codon at position 724 of the protein (p.Cys724X) in the evolutionarily conserved C5HC2 zinger finger domain. The mutation was not present in the latest dbSNP build 132 database and was detected in all available affected brothers and their mother, an obligate carrier.
As nonsense mutations in KDM5C have previously been shown to result in reduced KDM5C mRNA levels [8] , we test whether the novel nonsense c.2172C > A mutation found in the present family also affect the KDM5C mRNA level. Therefore, we performed RT-qPCR on RNA extracted from two affected brothers and two unaffected brothers. The two affected brothers both show reduced levels of KDM5C transcript as compared to the unaffected brothers (Table 1) , which strongly suggests that this novel nonsense mutation is implicated in the phenotype observed in the patients.
Within the last five years, twenty putative ID-related and one autism-related mutations were described along the KDM5C gene in peer-reviewed publications, including the one reported in this study. Among them, eight represent variants that lead to premature termination codons, including nonsense variants, small out-offrame deletions/insertions or intronic mutation [1, 8, 17, 18, 22] ( Table 2 ). The phenotype variability seen within and between families is probably due to the functional severity of the mutations, the existence of possible compensatory mechanisms by alternative histone demethylases and to other epigenetic and environmental modifying factors. Shared features among patients harboring these truncating mutations include mainly moderate to severe ID and short stature. Developmental delay in the language domain present in our patient has been previously reported in a family, in which ID segregates with a single-nucleotide insertion resulting in a pre- mature termination codon [17] . Moreover, speech delay has been also related to JARIDIC missense mutations among patients with ID [22] or autism [2] . Furthermore, the violent behavior exhibited by TRP and by other KDM5C mutated patients [8] is consistent with the higher expression of Jarid1c mRNA in certain brain regions of rodents, like bed nucleus of stria terminalis [23] . Among the ID-related truncating KDM5C mutations, only those reported by Jensen et al. [8] (p.R68fsX7, p.Arg694X and p.Trp1288X) and Rujirabanjerd et al. [17] (p.K1087fs(*)43) were evaluated for KDM5C expression stability, in addition to that reported in this study (p.Cys724X). Conversely to p.R68fsX7 and p.K1087fs(*)43 mutations, a significant reduction of KDM5C expression was seen for p.Arg694X, p.Trp1288X and p.Cys724X (see also Table 2 ), suggesting that the ID phenotype in the individuals carrying these mutations resulted from functional loss of KDM5C protein likely due to nonsense mediated mRNA decay (NMD) [3, 20] . This mechanism ensures the destruction of transcripts containing premature termination codons to prevent more harmful consequences for the cell. As to p.R68fsX7, where a loss of transcription was not observed, it is possible that the mutation leads to ID phenotype due to severe loss of essential JARIDIC protein domains or to the production of an anomalous protein from the alternative use of a methionine downstream of exon 2 [8] . In case of p.K1087fs(*)43, the premature termination codon associated with the mutation did not lead to degradation of the mRNA, probably because the insertion is only 52 nucleotides from the exon 22 to 23 boundary and thus insensitive or only partially sensitive to NMD [17] .
Nonsense mutations not just impair KDM5C activity, but can also disturb the functions of its target genes. Recently, a KDM5C expression profiling performed on lymphoblastoid cell lines and blood from patients with ID-related mutations in KDM5C identified several deregulated genes, including CMKOR1, KDM5B and the brain expressed KIAA0469 [9] . Also, a KDM5C complex isolated from HeLa cells showed additional components as chromatin modifiers (e.g. histone deacetylases HDAC1 and HDAC2, and the histone H3K9 methyltransferase G9a) and the RE-1 silencing transcription factor (REST) [21] . REST regulates the expression of many neuronal genes, of which some were already implicated in mental retardation, like brain-derived neurotropic factor (BDNF) [14] and the CACNA1B and CACNA1H, encoding calcium channels; SCL6A3 and SLC18A1, encoding monoamine transporters; and SLC6A12, encoding a GABA transporter. All these last six KDM5C target genes have been previously implicated in neurological disorders such as epilepsy, autism or schizophrenia [21] . KDM5C also interacts with Smad3, a DNA-binding transcription factor that mediates the transformation growth factor-␤ (TGF-␤) signaling. It suggests a role of KDM5C in tumorigenesis and in silico expression analysis showed an overexpression of this gene in prostate tumors and seminomas [11] . However, to the best of our knowledge, none of the mentally handicapped harboring KDM5C mutations manifested any kind of tumors. In contrast to other XLID genes, KDM5C has been highlighted as one of the most commonly mutated, justifying the time consuming evaluation of the whole gene and/or routine KDM5C expression analysis, mainly when a short stature phenotype segregates with ID in families with at least two affected male siblings. Furthermore, the identification of novel putatively disease-causing mechanisms associated to KDM5C can bring new clues to unravel the genetic causes of ID, besides it contributes to the understanding of the epigenetic network involved in neural function and learning. In addition, the perspective of reversing epigenetic marks may provide new pharmacological tools for therapeutic intervention.
